Objectives: To examine neonatal risk factors associated with recurrent Staphylococcus aureus colonization and to determine the genetic relatedness of S. aureus strains cultured from neonates before and after decolonization. Study design: Single-center retrospective cohort study of neonates admitted to the neonatal intensive care unit (NICU) from April 2013 to December 2015, during which weekly nasal cultures from hospitalized NICU patients were routinely obtained for S. aureus surveillance. Setting: Johns Hopkins Hospital's 45-bed level IV NICU in Baltimore, Maryland. Methods: Demographics and clinical data were collected on all neonates admitted to the NICU with S. aureus nasal colonization who underwent mupirocin-based decolonization during the study period. A decolonized neonate was defined as a neonate with ≥1 negative culture after intranasal mupirocin treatment. Pulsed-field gel electrophoresis was used for strain typing. Results: Of 2,060 infants screened for S. aureus, 271 (13%) were colonized, and 203 of these 271 (75%) received intranasal mupirocin. Of those treated, 162 (80%) had follow-up surveillance cultures, and 63 of these 162 infants (39%) developed recurrent colonization after treatment. The S. aureus strains were often genetically similar before and after decolonization. The presence of an endotracheal tube or nasal cannula/mask was associated with an increased risk of recurrent S. aureus colonization (hazard ratio [HR], 2.65; 95% confidence interval [CI], 1.19-5.90; and HR, 2.21; 95% CI, 1.02-4.75, respectively). Conclusion: Strains identified before and after decolonization were often genetically similar, and the presence of invasive respiratory devices increased the risk of recurrent S. aureus nasal colonization in neonates. To improve decolonization efficacy, alternative strategies may be needed. Cite this article: Akinboyo IC, et al. (2018). Epidemiology and risk factors for recurrent Staphylococcus aureus colonization following active surveillance and decolonization in the NICU.
Staphylococcus aureus remains the leading cause of pediatric nosocomial infections and a significant threat to hospitalized neonates in the United States. 1 Staphylococcus species, which constitute early components of the neonatal skin, nares and gastrointestinal microbiomes, continue to be responsible for the majority of neonatal late-onset sepsis (LOS). [2] [3] [4] [5] Staphylococcus aureus colonization often precedes invasive infections (eg, central-line-associated bloodstream infections (CLABSIs), bacteremia, pneumonia, and on rare occasions meningitis) putting premature infants at risk for long-term neurological sequelae. 4, [6] [7] [8] Historically, measures to decrease or eradicate S. aureus colonization, such as treatment with intranasal mupirocin, have focused on methicillin-resistant S. aureus (MRSA). However, rates of methicillin-susceptible S. aureus (MSSA) infections in the neonatal intensive care unit (NICU) outnumber MRSA, and infection-related mortality can be as high as 25% in very low birth weight infants (VLBW, weight <1,500 g). 2, 9 Active surveillance cultures and decolonization of colonized neonates have led to reduced rates of S. aureus transmission and infections, [10] [11] [12] [13] an approach that benefits the vulnerable neonate and concurrently, the general NICU population. 11, 14 Despite the success of decolonization as a strategy to reduce nosocomial infections, hospitalized neonates may develop recurrent S. aureus colonization, which increases the risk for ongoing transmission and infection within the NICU. 12, 15, 16 A previous study noted that up to half of the decolonized neonates who remain in the NICU for ≥ 21 days may develop recurrent MRSA nasal colonization. 17 Recurrent S. aureus colonization could be secondary to persistent endogenous reservoirs, environmental reservoirs (eg, healthcare workers, contaminated surfaces, or parents), or may be as a result of antimicrobial resistance. 14, 18, 19 No data are available describing factors that may impact the risk of recurrent S. aureus colonization in neonates. In this study, our objectives were to identify neonatal risk factors associated with recurrent S. aureus colonization after decolonization and to examine the genetic relatedness of S. aureus strains before and after decolonization.
Methods

Study design and population
We performed a retrospective cohort study of infants admitted to The Johns Hopkins Hospital's (JHH) 45-bed NICU from April 2013 to December 2015, a period of active surveillance and decolonization for both MSSA-and MRSA-colonized infants. The NICU has individual patient rooms and 2 separate medical teams with shared nursing staff providing quaternary care to more than 700 infants per year. The Johns Hopkins Institutional Review Board approved the study with a waiver of informed consent.
Case identification and definitions
Using administrative data, all neonates admitted to the NICU during the study period were identified and served as the source population. Microbiology data were collected from a computerized surveillance system (TheraDoc, Premier, Charlotte, NC) and merged with hospital billing data. The study cohort consisted of infants with S. aureus colonization, defined as an infant with 1 or more weekly nasal surveillance culture(s) that grew S. aureus during the initial NICU admission and who received intranasal mupirocin treatment after colonization. A retrospective chart review was conducted to identify clinical characteristics and demographic data at the time of S. aureus colonization. These data were collected and stored on a secure, online database hosted by REDCap. 20 Neonates with S. aureus nasal colonization underwent decolonization, per hospital protocol, which included a 5-day intranasal mupirocin treatment and topical chlorhexidine (CHG) antisepsis treatment, when age appropriate. 10 During the study period, CHG antisepsis was also part of other concurrent infection prevention bundles in the NICU. Therefore, an infant that received intranasal mupirocin treatment and had at least 1 negative nares surveillance culture after mupirocin treatment was classified as decolonized. The primary study outcome was recurrent colonization after decolonization with mupirocin.
Recurrent colonization was defined as growth of S. aureus from a surveillance culture after decolonization. Microbiological data for S. aureus infections, defined as clinical culture growth from a sterile site, were also collected. Stored bacterial isolates from a subset of infants with recurrent colonization after prolonged nasal clearance (ie, ≥ 2 negative surveillance cultures prior to recurrence of S. aureus colonization) were used for strain typing.
The following groups of infants were not eligible for the analytic cohort: (1) infants with no subsequent nares cultures after mupirocin treatment, (2) infants whose mupirocin treatments occurred before their first reported positive nares culture, (3) infants who had a subsequent negative surveillance culture prior to mupirocin treatment, and (4) infants with no negative surveillance cultures after decolonization ( Fig. 1 ).
Microbiology laboratory methods and bacterial isolate strain typing
All nasal surveillance S. aureus isolates were cultured and distinguished using selective chromogenic agar plates (SaSelect, BioRad, Hercules, CA). 10, 11, 21 Isolates were archived in tryptic soy broth with 20% glycerol at −80°C. As previously described, isolates were characterized by pulsed-field gel electrophoresis (PFGE) using SmaI-digested bacterial DNA 22, 23 and were analyzed with a molecular analyst fingerprinting plus software (Fingerprinting II version 3.0, BioRad). They were deemed genetically similar if they had ≤3 band differences (≥85% comparison score). 22 Mean comparison scores were measured for bacterial isolates. Gel images were maintained in a password-protected file so that within-and between-run comparisons could be performed for each group of isolates.
Statistical analysis
Continuous variables were summarized by both their means and standard deviations as well as their medians and interquartile ranges (IQRs). Categorical variables were reported as absolute counts and percentages. Kaplan-Meier estimates were calculated from (1) NICU admission to acquisition of S. aureus colonization and (2) S. aureus nasal decolonization to recurrent S. aureus colonization for infants who remained at risk ( Fig. 2 ). Discrete-time Cox proportional hazards were used to explore relationships between clinical factors (methicillin resistance, systemic or topical use of anti-Staphylococci antibiotics (except mupirocin), presence of a peripherally inserted central catheter (PICC), nasoenteric catheter, endotracheal tube, nasal respiratory cannula (or mask), and time (in weeks) from decolonization to recurrent colonization. Discrete-time logistic survival models were also estimated using least-angle shrinkage and selection operator (LASSO) with κ-fold cross validation (κ = 10) to perform shrinkage and variable selection due to the large number of coefficients relative to the sample size and number of events observed. 24 Analyses were performed using Stata version 14 software (StataCorp, College Station, TX) and R version 3.4.3 software (R Foundation for Statistical Computing, Vienna, Austria).
Results
Acquisition of S. aureus nasal colonization within the NICU
Of the 2,060 infants admitted to the NICU and screened for S. aureus during the study period, 271 (13%) were colonized with S. aureus ( Fig. 1 ). As shown in the Kaplan-Meier analysis (Fig. 2) , VLBW infants were significantly more likely to become colonized with S. aureus during NICU admission (log rank test, P = .003). Of the neonates with nasal S. aureus colonization, 203 received mupirocin intranasal treatment, and 167 of the treated infants had subsequent follow-up surveillance cultures. Of the 167 infants, 5 infants with MRSA never cleared S. aureus from surveillance cultures, while 162 infants had at least 1 negative surveillance culture after mupirocin treatment and were included in the analytic cohort. Fewer than 33% of the infants were colonized with MRSA (Table 1) .
At the time of S. aureus colonization, infants in the cohort were often premature and had been admitted to the NICU for nearly 3 weeks (Table 1) . Overall, 133 infants (81.5%) required respiratory support, and 132 (82%) had a nasally placed enteric tube. Nearly half of the infants (48.1%) had a central venous catheter inserted, and 63 infants (38.9%) had received an antibiotic with S. aureus activity (eg, cefazolin, clindamycin, cefepime, or vancomycin) in the week prior to documented growth of S. aureus from surveillance cultures. Clinical characteristics and demographics are summarized in Table 1 .
Association between clinical characteristics and time to recurrent colonization
Among the 162 decolonized infants, 63 (39%) had recurrent S. aureus colonization after treatment with intranasal mupirocin (Supplemental Fig. 3 ). The characteristics of infants with recurrent colonization were similar to the study cohort such that they were mostly premature infants, required respiratory support and/ or a nasoenteric tube, and most were colonized with MSSA (Table 1) . Using discrete-time Cox proportional hazards models to explore the relationship between clinical risk factors and time to recurrent colonization, we found that the risk of recurrent colonization after mupirocin treatment was higher for neonates with an endotracheal tube or nasal cannula/mask (hazard ratio [HR], 2.65; 95% confidence interval [CI], 1.19-5.90; and HR, 2.21; 95% CI, 1.02-4.75, respectively) ( Table 2 and Supplemental Fig.  4 ). Notably, methicillin resistance (HR, 1.4; 95% CI, 0.59-3.56), recent exposure to anti-S. aureus antibiotics (HR, 0.5; 95% CI, 0.31-1.07), and presence of a central venous catheter (HR, 0.9; 95% CI, 0.5-1.8) at the time of S. aureus colonization were not significantly associated with recurrent colonization after decolonization ( Table 2) .
Relatedness between S. aureus strains before and after decolonization
Of the 63 infants with recurrent colonization, 39 (62%) had stored isolates available for strain typing. Of these 39 neonates, 25 (64%) had S. aureus strains that were genetically similar before and after decolonization (mean comparison score, 97.8%; standard deviation [SD], 3.96). Also, 14 neonates (36%) acquired a S. aureus strain that was genetically different from their predecolonization strain (mean comparison score, 58.3%; SD, 9.17) .
Association between clinical characteristics and recurrent colonization with genetically similar strains
Among the 39 infants with isolates available for strain typing, there was an insignificant increase in the odds of recurrent colonization with concordant strains for those with nasoenteric tubes (odd ratio [OR], 1.43; 95% CI, 0.34-5.83), with nasal cannulas (OR, 1.5; 95% CI, 0.4-5.73) or with exposure to antibiotics in the week prior to S. aureus colonization (OR, 1.78; 95% CI, 0.47-6.89) ( Table 2) .
Discussion
Hospitalized neonates are at high risk for invasive S. aureus infections. 1 Decreasing neonatal nasal S. aureus burden, through decolonization, reduces risk of nosocomial infections. 11 In this retrospective study, we demonstrated that >33% of hospitalized neonates developed recurrent S. aureus nasal colonization after a mupirocin-based decolonization treatment. These infants were mostly colonized with genetically similar strains before and after decolonization. Prematurity and respiratory support devices, known risk factors for nosocomial infections, 25 were more common in infants with recurrent colonization. To our knowledge, this is the first study reporting NICU-patient level risk factors for S. aureus recurrent colonization and strain similarities before and after decolonization.
Prior studies have associated prolonged inpatient stays, prematurity, and vascular catheterization with S. aureus colonization. 8, [26] [27] [28] Because premature infants are frequently exposed to endogenous and exogenous reservoirs of S. aureus during extended NICU stays, 29 we postulated that factors associated with initial colonization may likely affect recurrent colonization. Our study suggests that infants with recurrent colonization were mostly premature, and the risk of recurrence was increased by presence of an endotracheal tube or nasal cannula/mask at the time of S. aureus colonization (Supplemental Fig. 4) . These data support the hypothesis that the frequent manipulation of respiratory equipment around the anterior nares or the creation of biofilms may increase the neonatal exposure to S. aureus reservoirs. 30 However, the presence of a vascular catheter and recent systemic exposure to anti-staphylococcal antibiotics, at the time of S. aureus colonization, did not affect time to recurrent colonization. Although many studies have documented the risk of recurrent colonization after treatment, our study compared the relatedness of strains identified from neonates before and after mupirocin-based decolonization. Our findings suggest that recurrent colonization was largely due to genetically similar strains, which supports prior suggestions that decolonization regimens may attenuate nasal bioburden rather eradicate S. aureus. 14, 17, 31 Additionally, extranasal sites of endogenous colonization may contribute to recurrent colonization. However, many hospitals perform nasal surveillance without testing other anatomic sites because the nares remain the principal reservoirs for S. aureus and the elimination of nasal carriage has been associated with decreased incidence of infections. 11, 32 Other factors may explain strain similarities before and after decolonization, such as ongoing exposure to a circulating strain within the NICU environment (ie, from HCWs, or reexposure to a colonized parent). 29 We did not find clonal S. aureus strains among infants included in the study, suggesting that neonates were not exposed to a common reservoir.
We demonstrated that nasally placed respiratory equipment was associated with a greater risk of recurrent colonization after decolonization. If these findings are replicated, clinicians could consider alternate decolonization strategies or attempt newer methods to eliminate S. aureus reservoirs, such as the use of antibiotic coated respiratory equipment to reduce transmission. Universal decolonization, contact isolation, and systemic antibiotics have been evaluated as alternative decolonization strategies with varying results. [33] [34] [35] Targeted decolonization for both MSSA and MRSA have not been extensively evaluated in neonates, but in adult patients with high risk of S. aureus infections, targeted decolonization and, at times, mupirocin prophylaxis have proven to be effective strategies. 10, 12, 15, 36 Future research could identify which of these strategies has the most benefit for neonates. After identifying infants at high risk for recurrent colonization, a systematic approach to rescreening and retreatment with mupirocin may also be beneficial. Questions regarding safety or antimicrobial resistance of mupirocin and CHG are beyond the scope of this study and could be included in future research. Moreover, numerous studies have reported minimal adverse effects or mupirocin resistance after implementation of active surveillance culture and decolonization. 11, 12, 14 This study has several limitations. Retrospective data collection and hospital-wide changes in electronic medical record software limited available clinical data. Small sample sizes, weekly S. aureus surveillance, and the single-center study design may have limited the ability to detect differences between groups, the precision of findings, and/or their generalizability. Prospective assessment of risk factors, daily S. aureus surveillance, or multicenter study design may provide findings that are more precise; however, feasibility and costs may be prohibitive. Staphylococcus aureus isolates from infants with recurrent colonization were stored at random and were available at our convenience. Nevertheless, a good proportion (62%) of recolonized infants had available isolates for strain typing. Data regarding CHG use in colonized infants could not be reliably obtained from the medical records. Exposure to CHG may have influenced rates of recurrent colonization, and this could be assessed in future studies. Finally, although PFGE remains the current gold standard for bacteria strain typing, PFGE can have some limitations in assessing genetic relatedness. 23 To further discriminate between isolates, other techniques, such as whole genome sequencing, could be used in future studies. 26, 37 Staphylococcus aureus colonization is common in the NICU. Neonates with recurrent colonization after mupirocin-based decolonization often have genetically similar strains of S. aureus before and after decolonization. To target neonates at greatest risk for recurrent colonization, clinicians may consider alternate decolonization strategies for premature infants requiring respiratory support equipment. 
